Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Vu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Pediatric and Adolescent Gynecology|October 8, 2011
Demodex folliculitisJohn R Vu, Joseph C English
Archives of Dermatology|October 17, 2012
Telaprevir-induced pityriasis rubra pilaris-like drug eruptionSimone S Stalling, John R Vu, Joseph C English
Oncotarget|May 30, 2019
Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphomaBrittany O Dulmage, Oleg Akilov, John R Vu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 12, 2017
In vivo induction of regulatory T cells promotes allergen tolerance and suppresses allergic contact dermatitisStephen C Balmert, Cara Donahue, John R Vu, et al.
Melanoma Research|April 19, 2014
Comparative proteomic analysis reveals unique tumor protein composition among the melanoma subtypes pure desmoplastic and superficial spreadingMichael K Schowalter, Brittany O Dulmage, Jonhan Ho, et al.
AIDS Research and Human Retroviruses|June 27, 2006
An immunoglobulin fusion protein based on the gp120-CD4 receptor complex potently inhibits human immunodeficiency virus type 1 in vitroJohn R Vu, Timothy Fouts, Katherine Bobb, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Pediatric and Adolescent Gynecology|October 8, 2011
Demodex folliculitisJohn R Vu, Joseph C English
Archives of Dermatology|October 17, 2012
Telaprevir-induced pityriasis rubra pilaris-like drug eruptionSimone S Stalling, John R Vu, Joseph C English
Oncotarget|May 30, 2019
Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphomaBrittany O Dulmage, Oleg Akilov, John R Vu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 12, 2017
In vivo induction of regulatory T cells promotes allergen tolerance and suppresses allergic contact dermatitisStephen C Balmert, Cara Donahue, John R Vu, et al.
Melanoma Research|April 19, 2014
Comparative proteomic analysis reveals unique tumor protein composition among the melanoma subtypes pure desmoplastic and superficial spreadingMichael K Schowalter, Brittany O Dulmage, Jonhan Ho, et al.
AIDS Research and Human Retroviruses|June 27, 2006
An immunoglobulin fusion protein based on the gp120-CD4 receptor complex potently inhibits human immunodeficiency virus type 1 in vitroJohn R Vu, Timothy Fouts, Katherine Bobb, et al.
Pageof 1